chr17-4446123-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_182538.5(SPNS3):​c.478G>A​(p.Val160Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,613,590 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000023 ( 0 hom. )

Consequence

SPNS3
NM_182538.5 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.547
Variant links:
Genes affected
SPNS3 (HGNC:28433): (SPNS lysolipid transporter 3, sphingosine-1-phosphate (putative)) Predicted to enable transmembrane transporter activity. Predicted to be involved in lipid transport and transmembrane transport. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.016487837).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SPNS3NM_182538.5 linkuse as main transcriptc.478G>A p.Val160Ile missense_variant 4/12 ENST00000355530.7 NP_872344.3 Q6ZMD2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SPNS3ENST00000355530.7 linkuse as main transcriptc.478G>A p.Val160Ile missense_variant 4/122 NM_182538.5 ENSP00000347721.2 Q6ZMD2-1
SPNS3ENST00000575194.5 linkuse as main transcriptn.341G>A non_coding_transcript_exon_variant 3/111 ENSP00000460781.1 I3L3W7
SPNS3ENST00000572078.1 linkuse as main transcriptn.269G>A non_coding_transcript_exon_variant 2/43
SPNS3ENST00000576069.5 linkuse as main transcriptn.352G>A non_coding_transcript_exon_variant 3/65 ENSP00000519557.1

Frequencies

GnomAD3 genomes
AF:
0.000112
AC:
17
AN:
152130
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000478
AC:
12
AN:
250980
Hom.:
0
AF XY:
0.0000369
AC XY:
5
AN XY:
135654
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.0000579
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000881
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000226
AC:
33
AN:
1461342
Hom.:
0
Cov.:
30
AF XY:
0.0000165
AC XY:
12
AN XY:
726962
show subpopulations
Gnomad4 AFR exome
AF:
0.000149
Gnomad4 AMR exome
AF:
0.000112
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000144
Gnomad4 OTH exome
AF:
0.0000994
GnomAD4 genome
AF:
0.000112
AC:
17
AN:
152248
Hom.:
0
Cov.:
32
AF XY:
0.000134
AC XY:
10
AN XY:
74444
show subpopulations
Gnomad4 AFR
AF:
0.000385
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000988
Hom.:
0
Bravo
AF:
0.0000793
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000494
AC:
6

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 27, 2022The c.478G>A (p.V160I) alteration is located in exon 4 (coding exon 4) of the SPNS3 gene. This alteration results from a G to A substitution at nucleotide position 478, causing the valine (V) at amino acid position 160 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
3.4
DANN
Benign
0.70
DEOGEN2
Benign
0.085
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.033
N
LIST_S2
Benign
0.70
T
M_CAP
Benign
0.0029
T
MetaRNN
Benign
0.016
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
-0.42
N
PrimateAI
Benign
0.31
T
PROVEAN
Benign
0.76
N
REVEL
Benign
0.033
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0030
B
Vest4
0.23
MVP
0.13
MPC
0.10
ClinPred
0.0053
T
GERP RS
-0.72
Varity_R
0.027
gMVP
0.20

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs372904010; hg19: chr17-4349418; COSMIC: COSV100337003; COSMIC: COSV100337003; API